Xemplifi 8103.0201S
Xemplifi 8103.0201S is a Class II device made by Globus Medical, Inc., cleared under FDA 510(k) K103036 on 10 Jan 2011 and listed in FDA GUDID since 10 Oct 2015 (UDI-DI 00889095205893), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00889095205893 | Date10 Oct 2015 | StatusListed |
| United States | FDA 510(k)SESE | NumberK103036 | Date10 Jan 2011 | StatusActive |
Official records
- AccessGUDID record 00889095205893
- FDA 510(k) database K103036
Across registries
- FDA 510(k) K103036 decided 10 Jan 2011 Active
- FDA GUDID UDI-DI 00889095205893 listed 10 Oct 2015 Listed
Timeline
- Cleared FDA 510(k) K103036
- Listed FDA GUDID 00889095205893
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Xemplifi
- Generic name
- Human-derived demineralized bone matrix implant
- Model / reference
- 8103.0201S
- Primary DI / UDI-DI
- 00889095205893
- 510(k) Number
- FDA product code
- MQV, MBP
- GMDN term
- Human-derived demineralized bone matrix implant
- Device class
- Class II
- Regulation number
- 888.3045
- GUDID distribution status
- In Commercial Distribution
- Size
- Total Volume — 1 Milliliter
Similar devices
Other devices filed under FDA product code MQV (FILLER, BONE VOID, CALCIUM COMPOUND).
- A-BSM BONE SUBSTITUTE MATERIAL by Etex Corp.
- DBX DEMINERALIZED BONE MATRIX PUTTY by Musculoskeletal Transplant Foundation
- CONNEXUS by ISOTIS ORTHOBIOLOGICS, INC
- OsteoFlo NanoPutty-Quadphasic Synthetic Bone Graft by SURGENTEC LLC
- FIBERGRAFT Aeridyan Matrix Bone Graft Substitute by Prosidyan, Inc.
- CALCIUM PHOSPHATE GRANULAR BONE VOID FILLER by Biomet, Inc.
- ABCcolla Bone Matrix by Acro Biomedical Co., Ltd.
- NuVasive AttraX Putty by Nu Vasive, Incorporated
- MODIFICATION TO: HEALOS BONE GRAFT MATERIAL by Depuy Spine, Inc.
- MagnetOs Putty by Kuros Biosciences B.V